SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool
暂无分享,去创建一个
Hans Ågren | Soumik Siddhanta | H. Ågren | T. Kundu | Chandrabhas Narayana | Karanam Balasubramanyam | Surabhi Sudevan | S. Perumal | C. Narayana | Tapas K Kundu | Dhanasekaran Karthigeyan | Annavarapu Hari Kishore | Sathya S R R Perumal | Surabhi Sudevan | Akshay V Bhat | Rangappa Kanchugarakoppal Subbegowda | Soumik Siddhanta | D. Karthigeyan | A. H. Kishore | R. Subbegowda | K. Balasubramanyam
[1] A. Denicola,et al. Study of protein‐ligand binding by fluorescence , 2002 .
[2] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[3] M. Goldflam,et al. NMR studies of protein-ligand interactions. , 2012, Methods in molecular biology.
[4] Rachel E. Gershman,et al. Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays , 2011, Clinical Cancer Research.
[5] S. Agrawal,et al. Specific small-molecule activator of Aurora kinase A induces autophosphorylation in a cell-free system. , 2008, Journal of medicinal chemistry.
[6] T. Kundu,et al. Surface-enhanced Raman spectroscopic studies of coactivator-associated arginine methyltransferase 1. , 2008, The journal of physical chemistry. B.
[7] Clive S Mason,et al. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237. , 2010, ACS chemical biology.
[8] Yonghua Wang,et al. Two TPX2-Dependent Switches Control the Activity of Aurora A , 2011, PloS one.
[9] T. Lüscher,et al. Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth. , 2002, Cardiovascular research.
[10] G. Bottegoni,et al. Small molecule aurora kinases inhibitors. , 2009, Current medicinal chemistry.
[11] Philippe Sanseau,et al. Evolutionary relationships of Aurora kinases: Implications for model organism studies and the development of anti-cancer drugs , 2004, BMC Evolutionary Biology.
[12] C. Sutherland,et al. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes. , 1988, Biochemical pharmacology.
[13] I. Schlichting. X-ray crystallography of protein-ligand interactions. , 2005, Methods in molecular biology.
[14] Wei Chen,et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase , 2007, Proceedings of the National Academy of Sciences.
[15] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[16] Duncan E McRee,et al. Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. , 2002, Structure.
[17] T. Kundu,et al. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy. , 2007, The journal of physical chemistry. B.
[18] Erica A. Golemis,et al. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis , 2012, Molecular biology of the cell.
[19] G. V. Pavan Kumar,et al. Surface-enhanced Raman scattering studies of human transcriptional coactivator p300. , 2006, The journal of physical chemistry. B.
[20] T. Hedner,et al. Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. , 1983, European journal of clinical pharmacology.
[21] R. Cortese,et al. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells , 2008, Molecular Cancer Therapeutics.
[22] R. Knegtel,et al. Crystal Structure of Aurora-2, an Oncogenic Serine/Threonine Kinase* , 2002, The Journal of Biological Chemistry.
[23] T. Kundu,et al. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy. , 2007, The journal of physical chemistry. B.
[24] S. Knapp,et al. Crystal Structure of Human Aurora B in Complex with INCENP and VX-680 , 2012, Journal of medicinal chemistry.
[25] Roland L. Dunbrack,et al. Rapid calcium-dependent activation of Aurora-A kinase , 2010, Nature communications.
[26] A. Mehdipour,et al. Dihydropyridine Derivatives to Overcome Atypical Multidrug Resistance: Design, Synthesis, QSAR Studies, and Evaluation of Their Cytotoxic and Pharmacological Activities , 2007, Chemical biology & drug design.
[27] A. Chakravarty,et al. MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy , 2007, Molecular and Cellular Biology.
[28] T. Hedner,et al. Felodipine — A new vasodilator, in addition to β-receptor blockade in hypertension , 2004, European Journal of Clinical Pharmacology.
[29] T. Kundu,et al. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. , 2007, Chemistry & biology.
[30] T. Kundu,et al. Surface enhanced Raman spectroscopy of Aurora kinases: direct, ultrasensitive detection of autophosphorylation , 2013 .
[31] Jindrich Cinatl,et al. Anti‐tumor mechanisms of valproate: A novel role for an old drug , 2002, Medicinal research reviews.
[32] Li-sheng Liu,et al. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients , 2005, Journal of hypertension.
[33] M. Morris,et al. EFFECTS OF DIHYDROPYRIDINES AND PYRIDINES ON MULTIDRUG RESISTANCE MEDIATED BY BREAST CANCER RESISTANCE PROTEIN: IN VITRO AND IN VIVO STUDIES , 2005, Drug Metabolism and Disposition.
[34] K. Maenaka,et al. Analysis of receptor-ligand interactions by surface plasmon resonance. , 2011, Methods in molecular biology.